尿道瘢痕形成的多因素分析

王周, 撒应龙. 尿道瘢痕形成的多因素分析[J]. 临床泌尿外科杂志, 2013, 28(2): 157-160.
引用本文: 王周, 撒应龙. 尿道瘢痕形成的多因素分析[J]. 临床泌尿外科杂志, 2013, 28(2): 157-160.
WANG Zhou, SA Yinglong. Multivariate analysis the formation of urethral scar[J]. J Clin Urol, 2013, 28(2): 157-160.
Citation: WANG Zhou, SA Yinglong. Multivariate analysis the formation of urethral scar[J]. J Clin Urol, 2013, 28(2): 157-160.

尿道瘢痕形成的多因素分析

详细信息
    通讯作者: 撒应龙,E-mail:sayinglong331@sina.com
  • 中图分类号: R695

Multivariate analysis the formation of urethral scar

More Information
  • 尿道手术后尿道瘢痕的形成是常见的并发症,常常影响尿道患者的术后康复,一直是泌尿外科医生面临的十分棘手的问题。由于其病因的复杂性,导致治疗效果往往不佳。本文通过对尿道瘢痕相关文献的分析,了解影响尿道瘢痕形成的一些因素,从而为尿道瘢痕的临床预防和治疗奠定理论依据。
  • 加载中
  • [1]

    Brown J J, Ollier W E, Thomson W, et al. Positive association of HLA-DRB1*15 with keloid disease in Caucasians[J]. Int J Immunogenet, 2008, 35:303-307.

    [2]

    王国胜, 李正天, 姜涛, 等. 家族遗传与非家族遗传性病理性瘢痕的基因芯片谱研究[J]. 哈尔滨医科大学学报, 2010, 44(2):142-147.

    [3]

    Salcido R S. The cicatrix:the critical functional stage of wound healing[J]. Adv Skin Wound Care, 2008, 21:402, 404.

    [4]

    Louw L. Keloids in rural black South Africans. Part 1:general overview and essential fatty acid hypotheses for keloid formation and prevention[J]. Prostaglandins Leukot Essent Fatty Acids, 2000, 63:237-245.

    [5]

    Marneros A G, Norris J E, Watanabe S, et al. Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11[J]. J Invest Dermatol, 2004, 122:1126-1132.

    [6]

    刘晓军, 高建华, 宋玫, 等. 中国汉族瘢痕疙瘩家系易感基因位点的定位分析研究[J]. 中国美容整形外科杂志, 2008, 19(3):179-183.

    [7]

    程飚, 付小兵, 盛志勇, 等. 瘢痕组织中α-平滑肌肌动蛋白的表达与细胞凋亡的关系[J]. 中国病理生理杂志, 2002, 18(11):1333-1336.

    [8]

    Luo S, Benathan M, Raffoul W, et al. Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions[J]. Plast Reconstr Surg, 2001, 107:87-96.

    [9]

    Funayama E, Chodon T, Oyama A, et al. Keratinocytes promote proliferation and inhibit apoptosis of the underlying fibroblasts:an important role in the pathogenesis of keloid[J]. J Invest Dermatol, 2003, 121:1326-1331.

    [10]

    Chen W, Fu X B, Ge S L, et al. Development of gene microarray in screening differently expressed genes in keloid and normal-control skin[J]. Chin Med J (Engl), 2004, 117:877-881.

    [11]

    Song J, Xu H, Lu Q, et al. Madecassoside suppresses migration of fibroblasts from keloids:involvement of p38 kinase and PI3K signaling pathways[J]. Burns, 2012, 38:677-684.

    [12]

    袁敬东, 胡葵葵, 胡琼华, 等. 瘢痕疙瘩胶原代谢机制研究进展[J]. 实用临床医学, 2003, 4(3):129-131.

    [13]

    黄翔, 张红英, 扬宇如, 等. 尿道瘢痕组织的病理学研究[J]. 临床泌尿外科杂志, 2003, 18(10):610-612.

    [14]

    Boyd J I 3rd, Wongworawat M D. High-pressure pulsatile lavage causes soft tissue damage[J]. Clin Orthop Relat Res, 2004, (427):13-17.

    [15]

    Verrecchia F, Mauviel A, Farge D. Transforming growth factor-beta signaling through the Smad proteins:role in systemic sclerosis[J]. Autoimmun Rev, 2006, 5:563-569.

    [16]

    Schiller M, Javelaud D, Mauviel A. TGF-beta-induced SMAD signaling and gene regulation:consequences for extracellular matrix remodeling and wound healing[J]. J Dermatol Sci, 2004, 35:83-92.

    [17]

    Sadick H, Herberger A, Riedel K, et al. TGF-beta1 antisense therapy modulates expression of matrix metalloproteinases in keloid-derived fibroblasts[J]. Int J Mol Med, 2008, 22:55-60.

    [18]

    Ihn H. Pathogenesis of fibrosis:role of TGF-beta and CTGF[J]. Curr Opin Rheumatol, 2002, 14:681-685.

    [19]

    Klass B R, Grobbelaar A O, Rolfe K J. Transforming growth factor beta1 signalling, wound healing and repair:a multifunctional cytokine with clinical implications for wound repair, a delicate balance[J]. Postgrad Med J, 2009, 85:9-14.

    [20]

    del Re E, Babitt JL, Pirani A, et al. In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2[J]. J Biol Chem, 2004, 279:22765-22772.

    [21]

    Derynck R, Zhang Y E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling[J]. Nature, 2003, 425:577-584.

    [22]

    Yamashita M, Fatyol K, Jin C, et al. TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta[J]. Mol Cell, 2008, 31:918-924.

    [23]

    Yu L, Hébert M C, Zhang Y E. TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses[J]. EMBO J, 2002, 21:3749-3759.

    [24]

    Chen W, Frangogiannis N G. Fibroblasts in post-infarction inflammation and cardiac repair[J]. Biochim Biophys Acta, 2012, Sep 7.

    [25]

    周庆余, 刘齐贵, 郭瑞威. 尿液刺激在尿道术后瘢痕形成中的作用[J]. 昆明医学院学报, 2011, 32(4):77-80.

    [26]

    Ten Dijke P, Goumans M J, Itoh F, et al. Regulation of cell proliferation by Smad proteins[J]. J Cell Physiol, 2002, 191:1-16.

    [27]

    Schiller M, Javelaud D, Mauviel A. TGF-beta-induced SMAD signaling and gene regulation:consequences for extracellular matrix remodeling and wound healing[J]. J Dermatol Sci, 2004, 35:83-92.

    [28]

    胡小勇, 徐月敏. 尿道狭窄的流行病学、病因学、组织学和分类[M]//徐月敏. 尿道狭窄修复重建外科学. 北京:人民卫生出版社, 2010:10-13.

    [29]

    Bourboulia D, Stetler-Stevenson W G. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs):Positive and negative regulators in tumor cell adhesion[J]. Semin Cancer Biol, 2010, 20:161-168.

    [30]

    Stetler-Stevenson W G. The tumor microenvironment:regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2[J]. Cancer Metastasis Rev, 2008, 27:57-66.

    [31]

    Ulrich D, Ulrich F, Unglaub F, et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids[J]. J Plast Reconstr Aesthet Surg, 2010, 63:1015-1021.

    [32]

    黄翔, 魏大鹏, 杨宇如, 等. 尿道瘢痕组织胶原酶活性及TIMP-1表达的研究[J]. 中国修复重建外科杂志, 2003, 17(6):433-435.

  • 加载中
计量
  • 文章访问数:  65
  • PDF下载数:  181
  • 施引文献:  0
出版历程
收稿日期:  2012-10-09

目录